CRB Monitor Securities Database Updates
During the week of July 17 - 23, 2023, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of July 17 - 23, 2023:
|
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
|
Tier 1A |
147 |
123 / 22 / 2 |
+0 | -0 | +0 |
|
Tier 1B |
728 |
577 / 149 / 2 |
+0 | -0 | +0 |
|
Tier 2 |
340 |
315 / 20 / 5 |
+1 | -0 | +1 |
|
Tier 3 |
504 |
476 / 27 / 1 |
+0 | -0 | +0 |
|
Total Issuances |
1,719 |
1,491 / 218 / 10 |
+1 | -0 | +1 |
|
Total Issuers (w/o Pre-IPOs) |
1,293 |
- |
+0 | -0 | +0 |
|
Total Issuers (w/ Pre-IPOs) |
1,303 |
- |
+1 | -0 | +1 |
- Added 1 Tier 2 Security:
- +1 = New CRB: ("Blackpoint Biotech PLC")
- +1 = New CRB: ("Blackpoint Biotech PLC")
All newly-identified CRBs during the week:
|
Company Name |
Tier |
Pure-Play | Sector |
Description |
|
(AQSE: BKPT) (Pre-IPO) |
2 | Yes | Health Care Equipment, Devices & Supplies | Blackpoint Biotech PLC is a UK-based biotech company whose products provide patients with measured, repeatable doses of specific cannabinoids to help treat their particular conditions. Blackpoints' inhalers and oral sprays are fast acting, discreet and reliable. They are available with different cannabinoid formulations to enable better treatment of different conditions. Blackpoint Biotech was established to fulfil gaps in the medical cannabis market by creating products that provide fast onset of action and accurate dosing. Blackpoint Biotech PLC is a Pre-IPO which intends to list on the Aquis Stock Exchange (AQSE) under the ticker symbol "BKPT". |